Migraderm Licensing & Service LLC is the exclusive agent representing AfGin Pharma, LLC, holder of US Patent No 8,329,734 B2. Click here to learn more.
Introducing a patented Topical Regional Neuro-Affective therapy for the treatment of migraine headaches. Click here to learn more.
The safety and effectiveness of this compound has not been demonstrated in a recognized clinical trial. Compounded drugs are not FDA-approved. The FDA does not verify the quality, safety and effectiveness of compounded drugs. Compounded drugs lack an FDA finding of manufacturing quality.
Migraderm Licensing and Service, LLC 90 Park Avenue, 17th Floor, New York, NY, 10016
© Copyright - 2013 Migraderm Licensing and Service, LLC